Sound Physicians
APRIL 28, 2025
While we’ve earned our reputation over the decades for our clinical excellence in hospital medicine , we’ve also earned — somewhat unfairly — a reputation for being more expensive than our competitors. On the face of things this may seem true, but I’d like to show you why we’re actually the most sustainable when it comes to your bottom line.
FDA Law Blog
OCTOBER 10, 2022
Criterion 4 : Non-Device CDS software functions provide sufficient information about the basis for the recommendations to the HCP user, so that the HCP user does not rely primarily on any of the recommendations to make a clinical decision about an individual patient. Interpretation of Statutory Criteria Under the Final Guidance.
FDA Law Blog
APRIL 8, 2024
Department of Health and Human Services (HHS) recently published a White Paper on Policy Considerations to Prevent Drug Shortages and Mitigate Supply Chain Vulnerabilities in the United States —with input from several HHS stakeholders, including FDA, CMS, and the Administration for Strategic Preparedness and Response. By Kalie E.
Expert insights. Personalized for you.
52 
Let's personalize your content